Hiroaki Nagata
- Cancer Research top 1%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- Circular RNAs in diseases 5
- Extracellular vesicles in disease 4
- RNA modifications and cancer 3
-
- Gastrointestinal disorders and treatments 3
-
- Gastrointestinal Tumor Research and Treatment 3
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Eigo OtsujiShuhei KomatsuDaisuke IchikawaAtsushi ShiozakiHirotaka KonishiKazuma OkamotoTomohiro AritaShoji Hirajima
- Partner nations
- JapanUnited States
In The Last Decade
Hiroaki Nagata
28 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 1.1k
- Molecular Biology 1.2k
- Oncology 207
- Energy Engineering and Power Technology 20
- Chemical Health and Safety 3
Countries citing papers authored by Hiroaki Nagata
This map shows the geographic impact of Hiroaki Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nagata more than expected).
Fields of papers citing papers by Hiroaki Nagata
This network shows the impact of papers produced by Hiroaki Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nagata. The network helps show where Hiroaki Nagata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroaki Nagata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 1 | |
| 3 | 2019 | 0 | |
| 4 | 2017 | 21 | |
| 5 | 2016 | 20 | |
| 6 | 2014 | 31 | |
| 7 | 2014 | 80 | |
| 8 | 2013 | 93 | |
| 9 | Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. | 2013 | 83 |
| 10 | 2013 | 188 | |
| 11 | 2013 | 98 | |
| 12 | 2012 | 171 | |
| 13 | 2012 | 68 | |
| 14 | 2012 | 77 | |
| 15 | 2011 | 214 | |
| 16 | 2008 | 4 | |
| 17 | 2008 | 2 | |
| 18 | 2008 | 1 | |
| 19 | MECHANISM OF THROMBOCYTOPENIA IN DOGS INFECTED WITH BABESIA GIBSONI | 1993 | 1 |
| 20 | [A müllerian duct cyst treated by injection of minocycline: a case report]. | 1993 | 1 |
About Hiroaki Nagata
Hiroaki Nagata is a scholar working on Chemical Health and Safety, Cancer Research and Gastroenterology, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (5 papers), Extracellular vesicles in disease (4 papers), Gastrointestinal disorders and treatments (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), RNA modifications and cancer (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations) and Oncology (207 citations). Hiroaki Nagata has collaborated with scholars based in Japan and United States. Frequent co-authors include Eigo Otsuji, Shuhei Komatsu, Daisuke Ichikawa, Atsushi Shiozaki, Hirotaka Konishi, Kazuma Okamoto, Tomohiro Arita, Shoji Hirajima, Tsutomu Kawaguchi and Hitoshi Fujiwara.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.